Equity Compensation (Tables)
3 Months Ended
Mar. 31, 2015
Equity Compensation  
Summary of stock option activity

 

 

 

 

Shares
Subject to
Options
Outstanding

 

Weighted
Average
Grant Date
Fair Value

 

Weighted
Average
Exercise
Price

 

Weighted
Average
Remaining
Contractual
Life (Years)

 

Balance at December 31, 2014

 

4,851,221

 

 

 

$

10.57

 

 

 

Granted

 

41,000

 

$

6.87

 

13.14

 

 

 

Exercised

 

(96,990

)

 

 

5.05

 

 

 

Expired

 

(5,074

)

 

 

11.41

 

 

 

Forfeited

 

(14,081

)

 

 

12.35

 

 

 

Balance at March 31, 2015

 

4,776,076

 

 

 

10.70

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable options at March 31, 2015

 

2,721,289

 

 

 

7.49

 

5.7

 

Vested and expected to vest at March 31, 2015

 

4,596,162

 

 

 

10.50

 

6.9

 

 

Summary of stock options outstanding and exercisable

 

 

 

Options Outstanding

 

Options Exercisable

 

Range of Exercise Prices

 

Weighted
Average
Exercise
Price

 

Number of
Underlying
Shares

 

Weighted-
Average
Remaining
Contractual
Life (in
years)

 

Number of
Underlying
Shares

 

Weighted-
Average
Remaining
Contractual
Life (in
years)

 

$0.78 - 1.72

 

$

1.10 

 

26,639 

 

0.5 

 

26,639 

 

0.5 

 

  1.97 - 3.38

 

2.57 

 

238,762 

 

1.6 

 

238,762 

 

1.6 

 

  3.58 - 6.14

 

5.66 

 

1,510,318 

 

5.4 

 

1,412,151 

 

5.4 

 

  6.34 - 9.94

 

8.29 

 

981,727 

 

7.0 

 

668,671 

 

6.9 

 

  11.28 - 16.97

 

13.91 

 

1,214,668 

 

8.8 

 

162,600 

 

6.2 

 

  17.66 - 22.92

 

21.00 

 

803,962 

 

8.9 

 

212,466 

 

8.8 

 

 

 

 

 

4,776,076 

 

 

 

2,721,289 

 

 

 

 

Summary of aggregate intrinsic-value of options exercised, exercisable, and vested and expected to vest

The following table summarizes the aggregate intrinsic-value of options exercised, exercisable and vested and expected to vest (in thousands):

 

 

 

For the three months ended
and as of March 31, 2015

 

Options Exercised

 

$

782 

 

Options Exercisable

 

14,232 

 

Options Vested and Expected to Vest

 

15,915 

 

 

Schedule of assumptions used to estimate fair value of option awards

 

 

 

 

Three Months Ended March 31,

 

 

 

2014

 

2015

 

Expected volatility

 

56 – 60

%

54 – 55

%

Expected dividends

 

0 

%

0 

%

Expected terms (in years)

 

3.8 – 6.1

 

6.1 

 

Risk-free rate

 

1.1 – 2.0

%

1.3 – 1.6

%

 

Schedule of total stock-based compensation expense classified in statements of operations

Total stock-based compensation expense has been classified as follows in the accompanying statements of operations (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2014

 

2015

 

Cost of revenue

 

$

20 

 

$

47 

 

Research and development

 

478 

 

772 

 

Sales and marketing

 

222 

 

454 

 

General and administrative

 

527 

 

576 

 

Total stock-based compensation expense

 

$

1,247 

 

$

1,849